Spectroscopic, computational, cytotoxicity, and docking studies of 6‐bromobenzimidazole as anti‐breast cancer agent

Abstract

Abstract6‐Bromobenzimidazole (6BBZ) has been calculated in this study utilizing the 6‐311++G(d,p) basis set and the Becke‐3‐Lee‐Yang‐Parr density functional approaches. The basic frequencies and geometric optimization are known. FTIR, FT‐Raman, and UV–Vis spectra of the substance are compared between its computed and observed values. The energy gap between highest occupied molecular orbital–lowest unoccupied molecular orbital and molecule electrostatic potentials has been represented by charge density distributions that may be associated with the biological response. Time‐dependent density functional theory calculations in the gas phase and dimethyl sulfoxide were carried out to ascertain the electronic properties and energy gap values using the same basis set. Molecular orbital contributions are investigated using the overlap population, partial, and total densities of states. Natural bond analysis was found to have strong electron delocalization by means of π(C4–C9) → π*(C5–C6), LP (N1) → π*(C7–C8), and LP(Br12) → π*(C5–C6) interactions. The Fukui function and Mulliken analysis have been explored on the atomic charges of the molecule. The nuclear magnetic resonance chemical shifts for 1H and 13C have been computed using the gauge‐independent atomic orbital technique. With the highest binding affinity (−6.2 kcal mol−1) against estrogen sulfotransferase receptor (PDB ID: 1AQU) and low IC50 value of 17.23 μg/mL, 6BBZ demonstrated potent action against the MCF‐7 breast cancer cell line. Studies on the antibacterial activity and ADMET prediction of the molecule have also been carried out.